Brief: Renovaro & Biosymetrics Announce Definitive Merger Agreement
26/02/2025 18:27
Feb 26 (Reuters) - Renovaro Inc RENB.O: RENOVARO AND BIOSYMETRICS ANNOUNCE DEFINITIVE MERGER AGREEMENT TO ADVANCE AI-DRIVEN BIOMARKER DISCOVERY AND PRECISION MEDICINE RENOVARO: DEAL EXPECTED TO CLOSE IN MARCH 2025 Source text: ID:nGNXbnCK1b Further company coverage: RENB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lunai Bioworks
See all newsNASDAQ RESUMED AT 02:16 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:06 PM
Brief: Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Brief: Lunai Bioworks Signs Agreement With Brainstorm Therapeutics
Brief: Lunai Bioworks - Regains Nasdaq Compliance With Minimum $1 Bid Price Rule - SEC Filing